Pcsk 9 mAb denied due to quantity / dose limits by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for pcsk9 mab are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UHC Applies Quantity Limits to PCSK9 Monoclonal Antibodies

UnitedHealthcare's pharmacy and medical policies set quantity limits for PCSK9 inhibitor monoclonal antibodies — typically expressed as a maximum number of units or injections per dispensing period — that align with the dosing schedule in the FDA-approved prescribing label. A quantity-limits denial most commonly occurs when the quantity requested on the prescription or claim exceeds that threshold, or when a supply has already been dispensed and the refill is being sought before the plan's refill-interval window opens. These are often administrative errors that can be corrected quickly, but they can also reflect a genuine coverage limit that requires a formal exception.

## Why This Denial Is Appealable

ACA §2719 and ERISA §503 both apply. If the quantity limit aligns strictly with the FDA-approved dosing schedule and your prescriber is ordering within that schedule, an administrative correction (resubmission with the correct quantity code) may resolve the denial without a formal appeal. If your prescriber believes a quantity above the standard limit is medically necessary — for example, because of a clinical circumstance documented in your chart — you can request a quantity-limit exception through UHC's appeal process. External review remains available if the exception is denied internally.

## The Appeal Process and Timeline

1. Confirm the specific limit: obtain UHC's published quantity-limit policy for this drug class. Compare it against the FDA-approved prescribing label dosing schedule. 2. Check for administrative error: verify that the prescription was written and transmitted with the correct quantity, days-supply, and refill timing. A coding correction may resolve the denial without an appeal. 3. If the limit is the issue: file a Level 1 internal appeal or exception request, supported by a prescriber letter explaining the medical necessity for the quantity requested. 4. Escalate to external review if the internal exception is denied.

## Documentation to Gather

• FDA-approved prescribing label: obtain the current label for the specific agent. The approved dosing schedule is the baseline; if your prescription matches it, present that clearly.
• Prescriber letter: if the requested quantity exceeds the standard limit, your prescriber should explain in writing the clinical rationale, supported by chart documentation.
• Pharmacy records: demonstrate dispensing history to clarify any refill-timing issue.
• UHC quantity-limit policy: obtain the current document and map your situation against every stated criterion.

## Criteria-Mapping Structure

Build your appeal around a direct comparison between the FDA-approved dosing schedule (from the prescribing label), UHC's stated quantity limit, and the quantity your prescriber ordered — with a specific clinical explanation for any discrepancy. If the quantities align, show that clearly and request administrative correction. If an exception is needed, use a table: left column lists each criterion in UHC's exception policy; right column provides the chart fact, date, and source that satisfies it. Attach the prescribing label and all referenced chart records as numbered exhibits.